Altamira Therapeutics Ltd. Proceeds From Exercise Of Warrants
Altamira Therapeutics Ltd. (CYTOF) reported Proceeds From Exercise Of Warrants of $2.64 million for the 6-month period ending 2024-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromExerciseOfWarrants · last filed 2025-08-29
CHF
| Period end | Proceeds From Exercise Of Warrants 12 month |
|---|---|
| 2023-12-31 | 541.03K CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | 1.23K CHF 20-F · filed 2023-05-16 |
| 2021-12-31 | 5.08K CHF 20-F · filed 2023-05-16 |
USD
| Period end | Proceeds From Exercise Of Warrants 6 month | Proceeds From Exercise Of Warrants 12 month | Proceeds From Exercise Of Warrants 12 month as first filed |
|---|---|---|---|
| 2024-06-30 | $2.64M 6-K · filed 2025-08-29 | ||
| 2023-12-31 | $614.90K 20-F · filed 2025-04-30 | $112.60K 6-K · filed 2024-09-24 |